Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount....
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount....
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety...
As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has...
Biological medicines have made substantial contributions to the treatment of many chronic and serious diseases and are expected to provide...
What are key challenges with treatment adherence among rare disease patients and how can we improve self-management of their condition?...
Healthy food cannot be defined by nutritional quality alone. It is the end result of a food system that conserves...
Late breaking data presented at European Lung Cancer Congress 2015 shows delay in disease progression of over a year AstraZeneca...
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a collaboration to conduct clinical...
AstraZeneca and MedImmune, the Company’s global biologics research and development arm, today announced that they have entered into an exclusive...
AstraZeneca and MedImmune, the company’s global biologics research and development arm, today presented encouraging results from their novel combination-focused immuno-oncology...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.